NX Development: NX Development Corp. Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan

LEXINGTON, KY / ACCESSWIRE / June 21, 2024 / NX Development Corp. (NXDC) is pleased to announce a significant milestone. Following the FDA's Orphan Designation for the diagnostic management of ovar...